Lipid formulations for nucleic acid delivery
US11141378B2 · kind B2 · utility
28Cited by
99References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 12, 2021 |
| Grant date | Oct 12, 2021 |
| Priority date | — |
| Expiry date | Apr 12, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/32
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel, stable lipid particles comprising one or more active agents or therapeutic agents, methods of making the lipid particles, and methods of delivering and/or administering the lipid particles. More particularly, the present invention provides stable nucleic acid-lipid particles (SNALP) comprising a nucleic acid (such as one or more interfering RNA), methods of making the SNALP, and methods of delivering and/or administering the SNALP.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.